European Regimen Accelerator for Tuberculosis
Grant Agreement no. 853989 — ERA4TB
era4tb.org
One week left to register for our webinar on "Modelling the Future: Early-Phase Development and HTA Insights from TBAJ-587".
📅 Date: 26 November 2025; 11am-12pm (GMT)
Register here: meetnice.zoom.us/webinar/regi...
One week left to register for our webinar on "Modelling the Future: Early-Phase Development and HTA Insights from TBAJ-587".
📅 Date: 26 November 2025; 11am-12pm (GMT)
Register here: meetnice.zoom.us/webinar/regi...
The poster informed readers, how key optimization tests that the hollow-fibre system, should require to allow reproducibility and robustness in its results.
The poster informed readers, how key optimization tests that the hollow-fibre system, should require to allow reproducibility and robustness in its results.
🕒 Only one day left!
ERA4TB, in collaboration with @NICEComms and the @WHO, are proud to introduce our speakers for tomorrow's webinar!
Register to save your spot: tinyurl.com/ERA4TB
🕒 Only one day left!
ERA4TB, in collaboration with @NICEComms and the @WHO, are proud to introduce our speakers for tomorrow's webinar!
Register to save your spot: tinyurl.com/ERA4TB
🕒 Only two days left! Do not miss our online webinar, focusing on tackling anti-microbial resistance through policy and partnerships
Register here: tinyurl.com/ERA4TB
🕒 Only two days left! Do not miss our online webinar, focusing on tackling anti-microbial resistance through policy and partnerships
Register here: tinyurl.com/ERA4TB
Well done to those involved!
Well done to those involved!
One week left to register for our webinar on 'Innovating Access: Tackling Anti-Microbial Resistance Through Policy'.
📅 Date: 8 October 2025; 1-2pm UK time
💻 Register here: tinyurl.com/ERA4TB
One week left to register for our webinar on 'Innovating Access: Tackling Anti-Microbial Resistance Through Policy'.
📅 Date: 8 October 2025; 1-2pm UK time
💻 Register here: tinyurl.com/ERA4TB
Well done Deborah Recchia, Maria Rosalia Pasca and the rest of our colleagues on creating such a fun and interactive experience!
Well done Deborah Recchia, Maria Rosalia Pasca and the rest of our colleagues on creating such a fun and interactive experience!
#ERA4TB Consortium Members from University of Pavia, hosted an interactive stand at Sharper Night - European Researchers' Night (2025).
#ERA4TB Consortium Members from University of Pavia, hosted an interactive stand at Sharper Night - European Researchers' Night (2025).
If you would like to know more about Deborah’s work with EUCAST or TBAJ-587, please reach out to us.
If you would like to know more about Deborah’s work with EUCAST or TBAJ-587, please reach out to us.
Deborah Recchia (University of Pavia) showcased two of her posters at SIMGM Congress.
The first poster, focused on the optimization of European Committee on Antimicrobial Susceptibility Testing (EUCAST).
Deborah Recchia (University of Pavia) showcased two of her posters at SIMGM Congress.
The first poster, focused on the optimization of European Committee on Antimicrobial Susceptibility Testing (EUCAST).
@amr-accelerator.bsky.social
@ihieurope.bsky.social
#Tuberculosis #TB #TranslationalResearch #Biomarkers #TimeKillAssays
@amr-accelerator.bsky.social
@ihieurope.bsky.social
#Tuberculosis #TB #TranslationalResearch #Biomarkers #TimeKillAssays
Diana shared how ERA4TB has built a robust translational platform to accelerate the progression of anti-TB drug candidates and combinatorial regimens.
#TBSky #TBResearch #DrugDevelopment
Diana shared how ERA4TB has built a robust translational platform to accelerate the progression of anti-TB drug candidates and combinatorial regimens.
#TBSky #TBResearch #DrugDevelopment
#TBSky #TBResearch
#TBSky #TBResearch
www.page-meeting.org/default.asp?...
#TBSky #TBResearch #Tuberculosis
www.page-meeting.org/default.asp?...
#TBSky #TBResearch #Tuberculosis
🔬Keynotes on antimicrobial resistance & new TB medicine development
💊Progress on TBAJ-587
🔍Novel drug testing approaches & mechanisms of action
@ihieurope.bsky.social @amr-accelerator.bsky.social @www.unizar.es
🔬Keynotes on antimicrobial resistance & new TB medicine development
💊Progress on TBAJ-587
🔍Novel drug testing approaches & mechanisms of action
@ihieurope.bsky.social @amr-accelerator.bsky.social @www.unizar.es
Lindsay Sonnenkalb from @fzborstel.bsky.social will be speaking on ‘New technologies for understanding drug resistance’. 25 minute slots will be available throughout the day.
➡️Book here: www.leibniz-gemeinschaft.de/ueber-uns/ne...
#Tuberculosis #TBResearch #TBSky
Lindsay Sonnenkalb from @fzborstel.bsky.social will be speaking on ‘New technologies for understanding drug resistance’. 25 minute slots will be available throughout the day.
➡️Book here: www.leibniz-gemeinschaft.de/ueber-uns/ne...
#Tuberculosis #TBResearch #TBSky
@pasteurlille.bsky.social at the #EMBOcellBioHostPath conference in Blois (France) presenting the ERA4TB host-pathogen interaction platform (BT08) and enjoying vivid discussions with TB experts in the field.
#TBSky #TBResearch
@pasteurlille.bsky.social at the #EMBOcellBioHostPath conference in Blois (France) presenting the ERA4TB host-pathogen interaction platform (BT08) and enjoying vivid discussions with TB experts in the field.
#TBSky #TBResearch